
    
      50 cases of HR-NDMM patients were divided into two groups nonrandomizedly. TE group received
      hematopoietic stem cell transplantation after induction therapy. Allo-sct for the young
      patients with suitable donors, Asct for the others. TNE group received consolidation therapy
      after induction therapy. All patients received PI-based maintenance therapy.
    
  